Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name：NCI-H661 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-F01
Human non-small-cell lung cancer cell lines
Strain Name：NCI-H1299 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-F16
Human non-small cell lung cancer cell line
Strain Name：NCI-H1155 Strain State ： Construction | Cat. NO.：NMC-240401
human non-small cell lung cancer cell line
Strain Name：HCC-95 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-F22
HCC-95 is a human non-small cell lung cancer (NSCLC), squamous cell carcinoma cell line.
Strain Name：NCI-H23 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-F19
NCI-H23 cell line was derived from a lung cancer obtained from a patient prior to therapy.
Strain Name：H22-Luc-hGPC3 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-GA01-TM05
The H22-Luc-hGPC3 cell line is the H22 liver cancer tumor cell line human GPC3 gene.
Strain Name：MC38-hCD24/hPD-L1 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-230052
The MC38-hCD24/hPD-L1 cell line is the MC38 colon cancer tumor cell line expressing human CD24 gene and human PD-L1 gene.
Strain Name：MC38-hCD47-hCLDN18.2-hEGFR Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-S13-TM73
The MC38-hCD47/hCLDN18.2/hEGFR cell line is the MC38 colon cancer tumor cell line expressing human CD47, human CLAUDIN18.2 gene and human EGFR gene.
Strain Name：HGC-27 Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-W03
HGC-27 was established by culture of the metastatic lymph node from a gastric cancer patient diagnosed histologically as undifferentiated carcinoma.
Strain Name：SW480 [SW-480] Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-J01
SW480 cells was isolated from the large intestine of a male Dukes B colorectal cancer patient.
Please fill in the order form and we will contact you within 2 working days.
